Event
Meeting
ID
IVD
IS
M
V
VCP
2 - 6 December, 2024 - 08:00 - 18:00 (CET)
UN City, Copenhagen,
Denmark
The United Nations Children Fund (UNICEF), the United Nations Population Fund (UNFPA) and the World Health Organization (WHO), held the annual 2024 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers from 2 to 6 December 2024 at UN City, Copenhagen, Denmark.
The theme of this year’s meeting was Ensuring Health Equity: "Partnerships for Accessible Quality Products".
Should you have any questions regarding the 2024 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers, please do not hesitate to contact us at prequal@who.int.
- Presentations of the 2023 Joint Meeting can be accessed here
Agenda
2024 Presentations
Day 1
Session 1
Session 2
- No presentations - Plenary Discussion - Check video "On-Demand" on the Event App
Session 3
- WHO’s role in strengthening the sustainability and quality of local production and technology transfer
- WHO Health Technology Access Program (HTAP) – A targeted approach to bridging the access gap
- Overcoming the challenges in local production to improve timely access of diagnostics
- Overcoming the challenges in local production to improve timely access of pharmaceuticals
- Overcoming the challenges in local production to improve timely access of vaccines
Session 4
Closing Day 1
Day 2
Session 5.1 - Prequalification of Diagnostics (PQT/IVD)
Session 5.2 - Prequalification of Medicines (PQT/MED)
- Introduction
- Update
- Bioequivalence Assessment Update
- Prequalification of biotherapeutic and biosimilar products
- API Assessment Update & ePQS Update
- Update on WHO Public Assessment Reports (WHOPARS)
Session 5.3 - Prequalification of Vaccines (PQT/VAX)
- WHO Vaccines PQ Overview
- Prequalification of Vaccines - CMC
- Prequalification of Vaccines - Clinical Requirements
- Prequalification of Vaccines - Programmatic Suitability
- Prequalification of Vaccines - Risk Benefit Assessment Procedures
- Prequalification of Vaccines - ePQS & eCTD
Session 5.4 - Prequalification of Vector Control Products (PQT/VCP)
Session 5.5 - UNFPA/WHO Prequalification of Contraceptive Devices
- Updates
- Review of Condom Customer Complaints 2023
- Review of Significant Changes by Condom Manufacturers 2023
- Specifications for Copper IUDs Variations
- Eco-friendly Condom Production
- Best Practices & Sustainability
- Innovative Projects on Condom Packaging Presentations
- Problems of Condom Supplies to High Altitude Locations
- Personal Lubricants & Osmolality
- Heating Ventilation and Air Conditioning Recommendations for Personal Lubricant Manufacture (HVAC)
- Update on Revision of ISO 4074 Ed. 4
Session 6 - Prequalification Inspection Services
- Introduction to WHO Prequalification Inspection Services
- Inspection Trends of API and FPP Manufacturing Sites and Quality Control Laboratories
- Good Document Practice in Bioequivalence Studies
- Vaccines Inspection Updates
- Update on Medical Devices Inspections
- Vector Control Products
- Desk Assessment and Reliance Approaches
- Update on new guidelines, DEG/EG Contamination, and the Use of New Technologies
Session 7 - Local Production & Technical Assistance
- PQ/EUL Related Specialized Technical Assistance
- PQ/EUL Related Specialized Technical Assistance for Diagnostics
- Specialized Technical Assistance (STA) for Medicines
- Specialized Technical Assistance (STA) for Vaccines
Day 3
Sessions 9 & 10 - Procurement & Supply Chain Updates
- World Health Organization - Procurement Overview
- The Global Fund's Procurement System
- Promoting Access to TB Products - GDF's 2024 Updates
- UNFPA Procurement and Strategic Sourcing
- Medical Procurement in UNHCR
- UNDP Global Health Procurement and Supply Chain Architecture
- Overview of PAHO Regional Revolving Funds
- UNICEF Supply Priorities Medicines
- Becoming a Supplier to UNICEF - Steps for Successful Engagement: Tendering and Contracting
- Becoming a Supplier to UNICEF - Steps for Successful Engagement - Quality Assurance for Pharma
- Becoming a Supplier to UNICEF - Technical Requirements for Pharmaceutical Products
- Traceability and Verification - TRVST Traceability & Verification System for Health Products
- Sustainable Procurement - Building Sustainable Supply Chains at UNICEF to Ensure a Live-able Planet for Every Child
- UNICEF Supply - Highlights & Priorities
- Last Mile Assurance and Supply Chain - Systems Strengthening
- UNFPA Product Quality Assurance
- Enhancing Collaboration Between Manufacturers and Global Procurers
Day 4
Session 11 - Regulatory Updates
- Implementing the WHO-listed Authority Framework - Achievements-Challenges-Benefits
- Experience and Perspective of WHO Collaborative Registration Procedure
- Norms and Standards for Biological Products: An Update
- Norms and Standards for Pharmaceuticals: An Update
Session 12 - Treatment and Diagnostic Guidelines, Essential Medicines Lists (Inc for Children), Essential In Vitro Diagnostics List
- Update on WHO TB Guidelines
- What Is New In Treatment and Diagnostics Guidelines - HIV, Viral Hepatitis and Sexually Transmitted Infections
- Non-Communicable Diseases (NCDs) - Global Context and Update
- Sexual and Reproductive Health and Research Department Update
- WHO Model List of Essential In Vitro Diagnostics
- WHO Model List of Essential Medicines
- Updates on Malaria: Diagnostics, Medicines and Vaccine
- World Health Emergencies and Living Guidelines
- Neglected Tropical Diseases (NTDs) Guidelines Update
Session 13 - Requirements for Storage and Transportation of Time and Temperature Sensitive Health Products
- Requirements for Storage and Transportation of Time and Temperature Sensitive Health Products (Temperature Control and Monitoring of Shipments)
- Innovations in Transportation of Time and Temperature-Sensitive Healthcare Products (TTSHP)
- UNICEF Supply Chain Delivery Strategy
Session 14 - PAHO Presentation & Official Closing
NTD-IVD Workshop
Day 1
- WHO NTD Diagnostics Technical Advisory Group
- WHO Target Product Profiles (TPP) - Process and Implications for WHO NTDs
- Access to NTD Diagnostics and WHO Response
- WHO Expert Review Panel for NTD Diagnostics (ERPD NTD)
Day 2
- Introduction to WHO Prequalification of In Vitro Diagnostics
- PQ Guidance Documents and ERPD Overview
- The ISO 13485: 2016 QMS - A Framework for a Safe, Efficient, and Effective IVD Medical Device(s)
- WHO Collaborative Registration Procedure for In vitro Diagnostics (CRP for IVDs)
- Post-Market Surveillance for IVDs
- WHO Health Technology Access Program (HTAP) – A Targeted Approach to Bridging the Access Gap